Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norman Muirhead

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 28, 2013
Biomarkers of inflammation, fibrosis, cardiac stretch and injury predict death but not renal replacement therapy at 1 year in a Canadian chronic kidney disease cohortAdeera Levin, Claudio Rigatto, Brendan Barrett, et al.
BMC Nephrology|June 14, 2013
Cohort profile: Canadian study of prediction of death, dialysis and interim cardiovascular events (CanPREDDICT)Adeera Levin, Claudio Rigatto, Barrett Brendan, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|December 9, 2010
Dialysis patients treated with Epoetin α show improved exercise tolerance and physical function: A new analysis of the Canadian Erythropoietin Study Group trialNorman Muirhead, Paul A Keown, David N Churchill, et al.
Canadian Journal of Kidney Health and Disease|June 15, 2018
Transfusion Management of Incident Dialysis Patients in Canada: A Prospective Observational StudyAminu K Bello, Christine M Ribic, Serge H Cournoyer, et al.
Transplantation|January 20, 2006
Intravenous immunoglobulin as a treatment for BK virus associated nephropathy: one-year follow-up of renal allograft recipientsAlp Sener, Andrew A House, Anthony M Jevnikar, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 27, 2003
Use of a pelvic kidney for living transplantation: case report and review of the literaturePatrick P W Luke, Vivian C McAlister, Anthony M Jevnikar, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 28, 2003
An operating cost comparison between conventional and home quotidian hemodialysisAndrew Kroeker, William F Clark, A Paul Heidenheim, et al.
Annals of Internal Medicine|August 2, 2006
Meta-analysis: risk for hypertension in living kidney donorsNeil Boudville, G V Ramesh Prasad, Greg Knoll, et al.
Kidney International|April 17, 2016
Advanced chronic kidney disease populations have elevated trimethylamine N-oxide levels associated with increased cardiovascular eventsRichard B Kim, Bridget L Morse, Ognjenka Djurdjev, et al.
Transplantation|March 28, 2003
Epstein-Barr virus seronegativity is a risk factor for late-onset posttransplant lymphoroliferative disorder in adult renal allograft recipientsVahakn B Shahinian, Norman Muirhead, Anthony M Jevnikar, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 28, 2013
Biomarkers of inflammation, fibrosis, cardiac stretch and injury predict death but not renal replacement therapy at 1 year in a Canadian chronic kidney disease cohortAdeera Levin, Claudio Rigatto, Brendan Barrett, et al.
BMC Nephrology|June 14, 2013
Cohort profile: Canadian study of prediction of death, dialysis and interim cardiovascular events (CanPREDDICT)Adeera Levin, Claudio Rigatto, Barrett Brendan, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|December 9, 2010
Dialysis patients treated with Epoetin α show improved exercise tolerance and physical function: A new analysis of the Canadian Erythropoietin Study Group trialNorman Muirhead, Paul A Keown, David N Churchill, et al.
Canadian Journal of Kidney Health and Disease|June 15, 2018
Transfusion Management of Incident Dialysis Patients in Canada: A Prospective Observational StudyAminu K Bello, Christine M Ribic, Serge H Cournoyer, et al.
Transplantation|January 20, 2006
Intravenous immunoglobulin as a treatment for BK virus associated nephropathy: one-year follow-up of renal allograft recipientsAlp Sener, Andrew A House, Anthony M Jevnikar, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 27, 2003
Use of a pelvic kidney for living transplantation: case report and review of the literaturePatrick P W Luke, Vivian C McAlister, Anthony M Jevnikar, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 28, 2003
An operating cost comparison between conventional and home quotidian hemodialysisAndrew Kroeker, William F Clark, A Paul Heidenheim, et al.
Annals of Internal Medicine|August 2, 2006
Meta-analysis: risk for hypertension in living kidney donorsNeil Boudville, G V Ramesh Prasad, Greg Knoll, et al.
Kidney International|April 17, 2016
Advanced chronic kidney disease populations have elevated trimethylamine N-oxide levels associated with increased cardiovascular eventsRichard B Kim, Bridget L Morse, Ognjenka Djurdjev, et al.
Transplantation|March 28, 2003
Epstein-Barr virus seronegativity is a risk factor for late-onset posttransplant lymphoroliferative disorder in adult renal allograft recipientsVahakn B Shahinian, Norman Muirhead, Anthony M Jevnikar, et al.
Pageof 5